Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody-Drug Conjugates.

Purcell JW, Tanlimco SG, Hickson J, Fox M, Sho M, Durkin L, Uziel T, Powers R, Foster K, McGonigal T, Kumar S, Samayoa J, Zhang D, Palma JP, Mishra S, Hollenbaugh D, Gish K, Morgan-Lappe SE, Hsi ED, Chao DT.

Cancer Res. 2018 Jul 15;78(14):4059-4072. doi: 10.1158/0008-5472.CAN-18-0327. Epub 2018 May 15.

PMID:
29764866
2.

Prenatal treatment of ornithine transcarbamylase deficiency.

Wilnai Y, Blumenfeld YJ, Cusmano K, Hintz SR, Alcorn D, Benitz WE, Berquist WE, Bernstein JA, Castillo RO, Concepcion W, Cowan TM, Cox KL, Lyell DJ, Esquivel CO, Homeyer M, Hudgins L, Hurwitz M, Palma JP, Schelley S, Akula VP, Summar ML, Enns GM.

Mol Genet Metab. 2018 Mar;123(3):297-300. doi: 10.1016/j.ymgme.2018.01.004. Epub 2018 Jan 16.

PMID:
29396029
3.

A "Prozone-Like" Effect Influences the Efficacy of the Monoclonal Antibody ABT-700 against the Hepatocyte Growth Factor Receptor.

Vaidya KS, Oleksijew A, Tucker LA, Pappano WN, Anderson MG, Grinnell CM, Zhang Q, Heighton SJ, Mitten MJ, Mishra S, Palma JP, Wang J, Reilly EB, Boghaert ER.

Pharmacology. 2017;100(5-6):229-242. doi: 10.1159/000478663. Epub 2017 Jul 26.

PMID:
28743107
4.

Changing Management of the Patent Ductus Arteriosus: Effect on Neonatal Outcomes and Resource Utilization.

Chock VY, Goel VV, Palma JP, Luh TM, Wang NA, Gaskari S, Punn R, Silverman NH, Benitz WE.

Am J Perinatol. 2017 Aug;34(10):990-995. doi: 10.1055/s-0037-1601442. Epub 2017 Apr 4.

PMID:
28376547
5.

ABBV-399, a c-Met Antibody-Drug Conjugate that Targets Both MET-Amplified and c-Met-Overexpressing Tumors, Irrespective of MET Pathway Dependence.

Wang J, Anderson MG, Oleksijew A, Vaidya KS, Boghaert ER, Tucker L, Zhang Q, Han EK, Palma JP, Naumovski L, Reilly EB.

Clin Cancer Res. 2017 Feb 15;23(4):992-1000. doi: 10.1158/1078-0432.CCR-16-1568. Epub 2016 Aug 29.

6.

Safety analysis of proposed data-driven physiologic alarm parameters for hospitalized children.

Goel VV, Poole SF, Longhurst CA, Platchek TS, Pageler NM, Sharek PJ, Palma JP.

J Hosp Med. 2016 Dec;11(12):817-823. doi: 10.1002/jhm.2635. Epub 2016 Jul 14. Review.

PMID:
27411896
7.

Health information exchange policies of 11 diverse health systems and the associated impact on volume of exchange.

Downing NL, Adler-Milstein J, Palma JP, Lane S, Eisenberg M, Sharp C; Northern California HIE Collaborative, Longhurst CA.

J Am Med Inform Assoc. 2017 Jan;24(1):113-122. doi: 10.1093/jamia/ocw063. Epub 2016 Jun 14.

PMID:
27301748
8.

Development of a Web-Based Decision Support Tool to Operationalize and Optimize Management of Hyperbilirubinemia in Preterm Infants.

Palma JP, Arain YH.

Clin Perinatol. 2016 Jun;43(2):375-83. doi: 10.1016/j.clp.2016.01.009. Epub 2016 Mar 11. Review.

PMID:
27235214
9.

Early experiences of accredited clinical informatics fellowships.

Longhurst CA, Pageler NM, Palma JP, Finnell JT, Levy BP, Yackel TR, Mohan V, Hersh WR.

J Am Med Inform Assoc. 2016 Jul;23(4):829-34. doi: 10.1093/jamia/ocv209. Epub 2016 May 20.

PMID:
27206458
10.

Failed endotracheal intubation and adverse outcomes among extremely low birth weight infants.

Wallenstein MB, Birnie KL, Arain YH, Yang W, Yamada NK, Huffman LC, Palma JP, Chock VY, Shaw GM, Stevenson DK.

J Perinatol. 2016 Feb;36(2):112-5. doi: 10.1038/jp.2015.158. Epub 2015 Nov 5.

11.

Case 1: Lactic Acidosis and Respiratory Distress in a 10-Day-Old Infant.

Wallenstein MB, Olson K, Peng DM, Stevenson DK, Shaw GM, Palma JP, Bain LC.

Neoreviews. 2015 Jul 1;16(7):e431-e433. No abstract available.

12.

Characterization of ABT-806, a Humanized Tumor-Specific Anti-EGFR Monoclonal Antibody.

Reilly EB, Phillips AC, Buchanan FG, Kingsbury G, Zhang Y, Meulbroek JA, Cole TB, DeVries PJ, Falls HD, Beam C, Gu J, Digiammarino EL, Palma JP, Donawho CK, Goodwin NC, Scott AM.

Mol Cancer Ther. 2015 May;14(5):1141-51. doi: 10.1158/1535-7163.MCT-14-0820. Epub 2015 Mar 2.

13.

Pulmonary hypertensive crisis following ethanol sclerotherapy for a complex vascular malformation.

Cordero-Schmidt G, Wallenstein MB, Ozen M, Shah NA, Jackson E, Hovsepian DM, Palma JP.

J Perinatol. 2014 Sep;34(9):713-5. doi: 10.1038/jp.2014.88.

14.

Red blood cell transfusion is not associated with necrotizing enterocolitis: a review of consecutive transfusions in a tertiary neonatal intensive care unit.

Wallenstein MB, Arain YH, Birnie KL, Andrews J, Palma JP, Benitz WE, Chock VY.

J Pediatr. 2014 Oct;165(4):678-82. doi: 10.1016/j.jpeds.2014.06.012. Epub 2014 Jul 16.

15.

Immunization registries in the EMR Era.

Stevens LA, Palma JP, Pandher KK, Longhurst CA.

Online J Public Health Inform. 2013 Jul 1;5(2):211. doi: 10.5210/ojphi.v5i2.4696. Print 2013.

16.

Impact of an EMR-Based Daily Patient Update Letter on Communication and Parent Engagement in a Neonatal Intensive Care Unit.

Palma JP, Keller H, Godin M, Wayman K, Cohen RS, Rhine WD, Longhurst CA.

J Particip Med. 2012 Dec 31;4. pii: e33.

17.

Using an Evidence-Based Approach to EMR Implementation to Optimize Outcomes and Avoid Unintended Consequences.

Longhurst CA, Palma JP, Grisim LM, Widen E, Chan M, Sharek PJ.

J Healthc Inf Manag. 2013;27(3):79-83.

18.

Anti-Ge3 causes late-onset hemolytic disease of the newborn: the fourth case in three Hispanic families.

Pate LL, Myers JC, Palma JP, Viele M, Galel SA, Ferrer Z, Gonzalez CL, Benitz WE, Garratty G, Fontaine MJ.

Transfusion. 2013 Oct;53(10):2152-7. doi: 10.1111/trf.12027. Epub 2012 Dec 12.

19.

Neonatal Informatics: Transforming Neonatal Care Through Translational Bioinformatics.

Palma JP, Benitz WE, Tarczy-Hornoch P, Butte AJ, Longhurst CA.

Neoreviews. 2012 May 1;13(5):e281-e284.

20.

Pyrazole diaminopyrimidines as dual inhibitors of KDR and Aurora B kinases.

Curtin ML, Heyman HR, Frey RR, Marcotte PA, Glaser KB, Jankowski JR, Magoc TJ, Albert DH, Olson AM, Reuter DR, Bouska JJ, Montgomery DA, Palma JP, Donawho CK, Stewart KD, Tse C, Michaelides MR.

Bioorg Med Chem Lett. 2012 Jul 15;22(14):4750-5. doi: 10.1016/j.bmcl.2012.05.067. Epub 2012 May 26.

PMID:
22695126
21.

Neonatal Informatics: Optimizing Clinical Data Entry and Display.

Palma JP, Brown PJ, Lehmann CU, Longhurst CA.

Neoreviews. 2012 Feb;13(2):81-85.

22.

Neonatal Informatics: Information Technology to Support Handoffs in Neonatal Care.

Palma JP, Van Eaton EG, Longhurst CA.

Neoreviews. 2011;2011(12). pii: e560.

23.

Pharmacodynamic evaluation of irinotecan therapy by FDG and FLT PET/CT imaging in a colorectal cancer xenograft model.

Mudd SR, Holich KD, Voorbach MJ, Cole TB, Reuter DR, Tapang P, Bukofzer G, Chakravartty A, Donawho CK, Palma JP, Fox GB, Day M, Luo Y.

Mol Imaging Biol. 2012 Oct;14(5):617-24. doi: 10.1007/s11307-011-0529-8.

PMID:
22167582
24.

Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitor.

Liu X, Shi Y, Maag DX, Palma JP, Patterson MJ, Ellis PA, Surber BW, Ready DB, Soni NB, Ladror US, Xu AJ, Iyer R, Harlan JE, Solomon LR, Donawho CK, Penning TD, Johnson EF, Shoemaker AR.

Clin Cancer Res. 2012 Jan 15;18(2):510-23. doi: 10.1158/1078-0432.CCR-11-1973. Epub 2011 Nov 29.

25.

Neonatal Informatics: Computerized Physician Order Entry.

Palma JP, Sharek PJ, Classen DC, Longhurst CA.

Neoreviews. 2011;12:393-396.

26.

Impact of electronic medical record integration of a handoff tool on sign-out in a newborn intensive care unit.

Palma JP, Sharek PJ, Longhurst CA.

J Perinatol. 2011 May;31(5):311-7. doi: 10.1038/jp.2010.202. Epub 2011 Jan 27.

27.

ABT-888 confers broad in vivo activity in combination with temozolomide in diverse tumors.

Palma JP, Wang YC, Rodriguez LE, Montgomery D, Ellis PA, Bukofzer G, Niquette A, Liu X, Shi Y, Lasko L, Zhu GD, Penning TD, Giranda VL, Rosenberg SH, Frost DJ, Donawho CK.

Clin Cancer Res. 2009 Dec 1;15(23):7277-90. doi: 10.1158/1078-0432.CCR-09-1245. Epub 2009 Nov 24.

28.

Identification of genes that confer tumor cell resistance to the aurora B kinase inhibitor, AZD1152.

Guo J, Anderson MG, Tapang P, Palma JP, Rodriguez LE, Niquette A, Li J, Bouska JJ, Wang G, Semizarov D, Albert DH, Donawho CK, Glaser KB, Shah OJ.

Pharmacogenomics J. 2009 Apr;9(2):90-102. doi: 10.1038/tpj.2008.20. Epub 2009 Feb 3.

PMID:
19188929
29.

The PARP inhibitor, ABT-888 potentiates temozolomide: correlation with drug levels and reduction in PARP activity in vivo.

Palma JP, Rodriguez LE, Bontcheva-Diaz VD, Bouska JJ, Bukofzer G, Colon-Lopez M, Guan R, Jarvis K, Johnson EF, Klinghofer V, Liu X, Olson A, Saltarelli MJ, Shi Y, Stavropoulos JA, Zhu GD, Penning TD, Luo Y, Giranda VL, Rosenberg SH, Frost DJ, Donawho CK.

Anticancer Res. 2008 Sep-Oct;28(5A):2625-35.

30.

Serum differentially modifies the transcription and translation of NMDAR subunits in retinal neurons.

Lee-Rivera I, López E, Palma JP, López-Colomé AM.

Neurochem Res. 2008 Aug;33(8):1442-51. doi: 10.1007/s11064-007-9572-x. Epub 2008 Feb 13.

PMID:
18270826
31.

Giant ulcerated pleomorphic liposarcoma of the chest wall.

Fernández EL, Plasencia LD, Palma JP, Pallares AC.

J Thorac Oncol. 2007 Dec;2(12):1126-7.

32.

ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models.

Donawho CK, Luo Y, Luo Y, Penning TD, Bauch JL, Bouska JJ, Bontcheva-Diaz VD, Cox BF, DeWeese TL, Dillehay LE, Ferguson DC, Ghoreishi-Haack NS, Grimm DR, Guan R, Han EK, Holley-Shanks RR, Hristov B, Idler KB, Jarvis K, Johnson EF, Kleinberg LR, Klinghofer V, Lasko LM, Liu X, Marsh KC, McGonigal TP, Meulbroek JA, Olson AM, Palma JP, Rodriguez LE, Shi Y, Stavropoulos JA, Tsurutani AC, Zhu GD, Rosenberg SH, Giranda VL, Frost DJ.

Clin Cancer Res. 2007 May 1;13(9):2728-37.

33.
34.
35.

Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft models.

Ferguson D, Rodriguez LE, Palma JP, Refici M, Jarvis K, O'Connor J, Sullivan GM, Frost D, Marsh K, Bauch J, Zhang H, Lin NH, Rosenberg S, Sham HL, Joseph IB.

Clin Cancer Res. 2005 Apr 15;11(8):3045-54.

36.

Innate immune response induced by Theiler's murine encephalomyelitis virus infection.

Kim BS, Palma JP, Kwon D, Fuller AC.

Immunol Res. 2005;31(1):1-12. Review.

PMID:
15591618
37.

Peptide mimotopes of Mycobacterium tuberculosis carbohydrate immunodeterminants.

Gevorkian G, Segura E, Acero G, Palma JP, Espitia C, Manoutcharian K, López-Marín LM.

Biochem J. 2005 Apr 15;387(Pt 2):411-7.

38.
39.
42.

Pathogenesis of virus-induced immune-mediated demyelination.

Kim BS, Lyman MA, Kang BS, Kang HK, Lee HG, Mohindru M, Palma JP.

Immunol Res. 2001;24(2):121-30. Review.

PMID:
11594451
43.

Enhanced susceptibility to Theiler's virus-induced demyelinating disease in perforin-deficient mice.

Palma JP, Lee HG, Mohindru M, Kang BS, Dal Canto M, Miller SD, Kim BS.

J Neuroimmunol. 2001 Jun 1;116(2):125-35.

PMID:
11438167
44.

Induction of selected chemokines in glial cells infected with Theiler's virus.

Palma JP, Kim BS.

J Neuroimmunol. 2001 Jul 2;117(1-2):166-70.

PMID:
11431017
45.

Pathogenic immunity in Theiler's virus-induced demyelinating disease: a viral model for multiple sclerosis.

Kim BS, Palma JP, Inoue A, Koh CS.

Arch Immunol Ther Exp (Warsz). 2000;48(5):373-9. Review.

PMID:
11140464
46.
47.
48.
50.

Supplemental Content

Loading ...
Support Center